Literature DB >> 24023593

Perception on adverse drug reaction reporting by physicians working in southern romania.

Marian Sorin Paveliu1, Simona Bengea-Luculescu, Mihai Toma, Silvia Fraga Paveliu.   

Abstract

AIM: The purpose of our study was to investigate and to assess the perceptions of Romanian doctors towards adverse drug reactions (ADRs) reporting.
METHOD: A questionnaire with 20 items accompanied by a letter presenting the study was circulated using Internet and face to face interviews to 532 doctors in Bucharest and two neighboring regions from Romania (Muntenia and Oltenia).
RESULTS: 204 (56.2%) of the total number of responders expressed their opinion that the daily number of ADRs observed to be under 5 309 (58%) of responders were never informed about ADRs reporting, 439 (82.52%) did not know that the Romanian College of Physicians is scoring this activity under the "Continuous medical education program". Factors that might encourage voluntary reporting of adverse reactions were identified to be: the easiness of reporting, their periodic information and the training about all adverse reactions reported by doctors and the measures taken. Factors discouraging voluntary reporting of an adverse drug reaction were: the lack of information on where, when and how to report ADRs, the uncertain causality.
CONCLUSION: Currently, the pharmacovigilance activities including reporting of ADRs in Romania are more of an accidental nature, doctors are less or not at all informed about this activity. Doctors have a favorable attitude towards reporting ADRs - as the majority believes that the reporting should be either voluntary or mandatory as opposed to a small number that would expect to be paid for this activity.

Year:  2013        PMID: 24023593      PMCID: PMC3749755     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  15 in total

1.  Learning about the safety of drugs--a half-century of evolution.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

2.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

3.  Troglitazone: the lesson that nobody learned?

Authors:  Edwin A M Gale
Journal:  Diabetologia       Date:  2006-01       Impact factor: 10.122

4.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges.

Authors:  Amalia M Issa
Journal:  Pharmacogenomics       Date:  2003-09       Impact factor: 2.533

6.  Attitudes to adverse drug reaction reporting.

Authors:  W H Inman
Journal:  Br J Clin Pharmacol       Date:  1996-05       Impact factor: 4.335

7.  Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.

Authors:  M Cosentino; O Leoni; F Banfi; S Lecchini; G Frigo
Journal:  Pharmacol Res       Date:  1997-02       Impact factor: 7.658

8.  Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania.

Authors:  Andreea Farcas; Aura Sinpetrean; Cristina Mogosan; Mariana Palage; Oliviu Vostinaru; Marius Bojita; Dan Dumitrascu
Journal:  Eur J Intern Med       Date:  2010-06-23       Impact factor: 4.487

Review 9.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

10.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data.

Authors:  Jürgen Stausberg; Joerg Hasford
Journal:  BMC Health Serv Res       Date:  2011-05-29       Impact factor: 2.655

View more
  6 in total

1.  Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Authors:  Susann Muehlhans; Max von Kleist; Tatiana Gretchukha; Martin Terhardt; Ulrich Fegeler; Wolfgang Maurer; Leila Namazova-Baranova; Gerhard Gaedicke; Alexander Baranov; Barbara Rath
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

2.  Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.

Authors:  Dorota Kopciuch; Nashwa Nabil Kamal; Nashaat Nabil Kamal; Nermin Aly Hamdy; Anna Paczkowska; Tomasz Zaprutko; Piotr Ratajczak; Jędrzej Fliciński; Krzysztof Kus; Elżbieta Nowakowska
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

3.  Psychometric Properties of the Romanian Version of the Hospital Survey on Patient Safety Culture (HSOPS).

Authors:  Carmen Tereanu; Scott Alan Smith; Mugurel Stefan Ghelase; Giuseppe Sampietro; Adrian Molnar; Antoaneta Dragoescu; Florentina Ligia Furtunescu; Camelia Stanescu; Olguta Alice Gavrila; Anca Patrascu; Andreea Loredana Golli; Manuela Dragomir
Journal:  Maedica (Bucur)       Date:  2018-03

4.  Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.

Authors:  H M Haines; J C Meyer; R S Summers; B B Godman
Journal:  Eur J Clin Pharmacol       Date:  2020-04-15       Impact factor: 2.953

5.  A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan.

Authors:  Rabia Hussain; Mohamed Azmi Hassali; Furqan Hashmi; Maryam Farooqui
Journal:  J Pharm Policy Pract       Date:  2018-07-19

6.  Adverse drug reaction reporting among physicians working in private and government hospitals in Kuwait.

Authors:  F M Alsaleh; J Lemay; R R Al Dhafeeri; S AlAjmi; E A Abahussain; T Bayoud
Journal:  Saudi Pharm J       Date:  2017-09-13       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.